Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared
Vantage Report 2018: Research Dragged, but Biotech IPOs and Startups Soared
Deloitte: 2019 Global life sciences outlook report
Deloitte: 2019 Global life sciences outlook report
The Global Use of Medicine in 2019 and Outlook to 2023
The Global Use of Medicine in 2019 and Outlook to 2023
2019 Trends Brief from PwC
2019 Trends Brief from PwC
New Industry Report Finds Most Orphan Drugs Aren’t Successful
The 2018 Trinity Drug Index
Biopharma in 2019
Biopharma in 2019
»Drug Developments in Prostate Cancer» report
Men’s Health: Drug Developments in Prostate Cancer » report
Potential of First-in-Class Epidiolex for Epilepsy and its Significance in the Advent of Medical Marijuana
Potential of First-in-Class
Epidiolex for Epilepsy and its
Significance in the Advent
of Medical Marijuana
Vantage Pharma, Biotech & Medtech Half-Year Review 2018
The Vantage Half-Year Review 2018 shows that biopharma small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers. Our report … Continue Reading Vantage Pharma, Biotech & Medtech Half-Year Review 2018
Q3 2018 Outlook Report
Download an extract of the data-rich resource: Biomedtracker’s Q3 2018 Outlook Report. This latest installment in Biomedtracker’s ongoing quarterly reports contains expected drug catalyst predictions, important clinical and … Continue Reading Q3 2018 Outlook Report
Innovations in Oncology: The Cancer Moonshot and Beyond [eBook]
This eBook is a celebration of the innovative efforts driving cancer research forward. Download this eBook to: Discover the diverse and innovative projects propelling the Cancer Moonshot forward Read thought-provoking … Continue Reading Innovations in Oncology: The Cancer Moonshot and Beyond [eBook]
Brexit Implications for Pharma Article Pack
Discover why Brexit Won’t Delay Drug Approvals. Plus how the #UK & the #EuropeanMedicinesAgency could work together informally after #Brexit. Download the full article pack & learn more: Brexit Implications for Pharma Article Pack V2 … Continue Reading Brexit Implications for Pharma Article Pack
2017 Completed Trials report
Status Quo or No? As Informa Pharma Intelligence has done for the past three years, this analysis examines the landscape of industry-sponsored clinical trials completed during 2017, of which there were … Continue Reading 2017 Completed Trials report
Pharma Asset Insights report
Innovation in the pharmaceutical industry has never been more exciting, and complicated. Disruptive technologies, such as artificial intelligence and digital health tools, and advanced therapeutic modalities including cell and gene … Continue Reading Pharma Asset Insights report
Clinical Genomics 101: 2018 Edition
The last twelve months have seen many advances within the field of genomics. The price of sequencing and analysis has continued to drop dramatically and accuracy gets better with … Continue Reading Clinical Genomics 101: 2018 Edition
Cancer Genomics 101: 2018 Edition
Cancer is one of the oldest diseases known to human society, and recently it’s the development of next-generation sequencing and a stronger understanding of genetic mutations that have driven … Continue Reading Cancer Genomics 101: 2018 Edition
